Vectus Biosystems (ASX:VBS) Short-Term Capital Lease Obligation

: A$0.00 Mil (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

Vectus Biosystems's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2022 was A$0.00 Mil.

Vectus Biosystems's quarterly Short-Term Capital Lease Obligation increased from Dec. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.06 Mil) but then declined from Jun. 2022 (A$0.06 Mil) to Dec. 2022 (A$0.00 Mil).

Vectus Biosystems's annual Short-Term Capital Lease Obligation declined from Jun. 2020 (A$0.02 Mil) to Jun. 2021 (A$0.02 Mil) but then increased from Jun. 2021 (A$0.02 Mil) to Jun. 2022 (A$0.06 Mil).

Vectus Biosystems Short-Term Capital Lease Obligation Historical Data

The historical data trend for Vectus Biosystems's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Short-Term Capital Lease Obligation

0.02

0.06

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Short-Term Capital Lease Obligation										-	0.02	-	0.06	-

Vectus Biosystems Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Vectus Biosystems Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems (ASX:VBS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018

Website

http://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines